Alumis Quarterly Balance Sheet
NASDAQ: ALMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alumis financial position
As of Jun 30, 2026, Alumis reported total assets of $560.6 million, down 8.2% from a year earlier against total liabilities of $108.5 million. Shareholders' equity stood at $452.2 million, or 80.7% of assets. The company held $63.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 6.74, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Alumis balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 63.71M | 63.88M | 89.67M | 65.26M | 151.75M | 128.54M | 169.53M | 213.42M | 155.11M | 112.07M | 46.00M | 53.94M |
| Short-Term Investments | — | — | 218.83M | 312.47M | 334.57M | 80.21M | 118.74M | 148.45M | 54.42M | — | 2.96M | — |
| Total Current Assets | 514.08M | 532.41M | 318.23M | 393.29M | 517.56M | 225.53M | 306.19M | 377.35M | 224.86M | — | 53.36M | — |
| Property, Plant & Equipment | 16.85M | 17.53M | 18.19M | 19.06M | 20.33M | 20.33M | 20.97M | 21.43M | 22.17M | — | 22.44M | — |
| Total Assets | 560.62M | 671.59M | 411.94M | 488.01M | 610.92M | 261.30M | 340.99M | 412.56M | 265.18M | — | 89.61M | — |
| Accounts Payable | 12.80M | 11.59M | 10.11M | 4.55M | 14.98M | 7.47M | 9.62M | 6.44M | 9.19M | — | 1.12M | — |
| Total Current Liabilities | 76.23M | 70.90M | 73.32M | 65.42M | 85.58M | 60.45M | 50.91M | 33.52M | 33.41M | — | 20.87M | — |
| Total Liabilities | 108.46M | 104.57M | 110.64M | 103.24M | 125.60M | 92.98M | 80.89M | 64.17M | 64.70M | — | 53.50M | — |
| Shareholders' Equity | 452.16M | 567.02M | 301.30M | 384.77M | 485.33M | 168.31M | 260.10M | 348.39M | -438.75M | -385.93M | -339.26M | -303.07M |
| Retained Earnings | -1.14B | -994.93M | -901.88M | -808.95M | -698.19M | -757.51M | -658.55M | -563.79M | -470.68M | — | -364.32M | — |
| Net Cash (Debt) | 63.71M | 63.88M | 308.50M | 377.72M | 486.32M | 208.75M | 288.26M | 361.87M | 209.53M | 112.07M | 48.95M | 53.94M |
This table shows 12 quarterly periods of Alumis's balance sheet, from Q2 2026 back to Q3 2023, across 11 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow ALMS's reporting calendar. What is a balance sheet?